Exchange: NASDAQ·Updated 07:30 PM EDT

KLRA Kailera Therapeutics Inc.

$16.23
$0.49
(3.11%)
Today
Closed $16.23
$0.23
(1.42%)
After Hours
EarningsOct 29
Mkt Cap$2.1B
Vol524,424.00

About KLRA

Kailera Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Its product candidate includes Ribupatide. The company was founded on May 08, 2024 and is headquartered in Waltham, MA.
56

Bullish Sentiment

How do you feel about KLRA?

Advertisement|Remove ads.